SCHEMBL1156567

SCHEMBL1156567

CC(C)(C)C(Cc1cc(-c2ccsc2)n(S(=O)(=O)c2cccc(Cl)c2)c1)NC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.34
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
PTGDR2 Q9Y5Y4 2/20 0.34
IDH2 P48735 1/20 0.34
ITGB1 P05556 3/20 0.33
ITGA4 P13612 3/20 0.33
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
MCTS1 Q9ULC4 1/20 0.33
ITGB7 P26010 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
PTGS2 P35354 2/20 0.33
CPT1A P50416 2/20 0.33
CPT1B Q92523 2/20 0.33
HTR6 P50406 5/20 0.33
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1156908 0.86 HTR6 (0.40) PTGDR2PTGS2HTR6HTR1ADRD2
SCHEMBL1156468 0.86 SLC1A3 (0.35) SLC1A3SLC1A2SLC1A1IDH2ITGB1
SCHEMBL1157092 0.85 SLC1A3 (0.40) SLC1A3SLC1A2SLC1A1PTGDR2IDH2
SCHEMBL1156560 0.82 PTGDR2 (0.39) SLC1A3SLC1A2SLC1A1PTGDR2ITGB1
SCHEMBL1156777 0.81 AKR1C3 (0.37) IDH2CPT1ACPT1BHTR6DRD2
SCHEMBL1762992 0.79 PRMT6 (0.44) MMP2HTR6
SCHEMBL1156772 0.79 AOC3 (0.39) PTGDR2HTR6CTSLCTSS
SCHEMBL1156570 0.79 LMNA (0.35) PTGDR2IDH2SLC16A3SLC16A1MCTS1
Hydrochloric Acid SCHEMBL1156568 0.78 PRMT6 (0.44) MMP2HTR6
SCHEMBL1157051 0.77 ADAMTS4 (0.39) ITGB1ITGA4ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048909-B2 Proton pump inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-11-01 US disclosed
EP-2336107-A2 Proton pump inhibitors Takeda Pharmaceutical Company Limited (JP) 2011-06-22 EP disclosed
US-20110028476-A1 PROTON PUMP INHIBITORS KAJINO MASAHIRO 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028476-A1 PROTON PUMP INHIBITORS HRH2, HRH4, CYP2C19 SLC1A3 1705/4885SLC1A2 1872/4885SLC1A1 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.